EMA-Defined Tinnitus Subgroups

Status Completed

Clinical Trial Summary

The purpose of this research study is to test a new way of measuring the severity of tinnitus using a tool called Ecological Momentary Assessment (EMA) of Tinnitus. We will compare the relationship with this tool with another widely used questionnaire. Previous studies we have done suggest there are different patterns of tinnitus bother; we plan to explore how often these patterns occur, and how many patterns of tinnitus bother there are. And lastly we want to test how reliable this type of testing is for measuring the amount of bother people experience from their tinnitus.

Hypothesis 1: We will be able to identify 6 or more distinctive patterns of tinnitus.

Hypothesis 2: EMA will provide a reliable method for more accurately capturing the amount of bother individuals have from tinnitus.

Clinical Trial Description

You to need to complete this brief survey to determine if you meet the criteria for participation in the study. You are free to skip any questions that you prefer not to answer. We will only use the information you provide in this survey to determine if you qualify for the EMA-Defined Tinnitus Subgroups study.

To be in this study, you will be required to have a smart phone that can receive text messages, is connected to the internet, and will allow you to connect via the internet to a Washington University secure server. It is necessary to connect to the Washington University server in order to complete a short survey four times a day for two separate two-week periods.

The study involves us sending you text messages at 4 random times during the day, between the hours of 8: 00 am - 9: 00 pm. The texts prompt you to click on a link and respond to a short EMA survey regarding what you are doing, what your environment is, and how your tinnitus is at that moment. These text messages will be sent daily for two weeks. Then you will have two weeks off. Finally you will again receive the text messages asking for you to respond to the survey for two more weeks. You will receive a total of 112 text messages over four weeks. In addition we will send you four emails or texts asking you to complete a survey at the following times: before you complete your first set of EMA surveys, at the end of the first set EMA surveys, prior to starting the second set of EMA surveys, and a final time after you have completed the final EMA survey. This study requires no visits to Washington University.

In order to participate you must complete this short prescreening survey to see if you qualify. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Tinnitus

Clinical Trial Details

NCT number	NCT02191592
Study type	Observational [Patient Registry]
Source	Washington University School of Medicine
Contact
Status	Completed
Phase	N/A
Start date	July 2014
Completion date	February 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05963542` - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia	N/A
Recruiting	`NCT04987502` - Virtual Reality and Subjective Tinnitus	N/A
Recruiting	`NCT04404439` - Treatment of Tinnitus With Migraine Medications	Phase 4
Recruiting	`NCT05533840` - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Completed	`NCT03552302` - Effects of Yoga Exercise on Participates With Tinnitus
Enrolling by invitation	`NCT02617953` - Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus	N/A
Completed	`NCT02974543` - Somatosensory Stimulation to Alleviate Tinnitus	N/A
Completed	`NCT02269839` - A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus	N/A
Withdrawn	`NCT01663467` - Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy	N/A
Completed	`NCT01929837` - Tinnitus rTMS 2013	N/A
Completed	`NCT01857661` - The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial	N/A
Completed	`NCT01927991` - Internet-based Self-help for Tinnitus: The Role of Support	N/A
Completed	`NCT01480193` - New Therapy for Patients With Severe Tinnitus	N/A
Terminated	`NCT01412918` - Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression	N/A
Completed	`NCT00748475` - Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus	N/A
Completed	`NCT00371436` - Progressive Intervention Program for Tinnitus Management	N/A
Completed	`NCT00733044` - Cost-effectiveness of Multidisciplinary Management of Tinnitus	N/A
Active, not recruiting	`NCT05518682` - Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus	N/A
Recruiting	`NCT05212298` - Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus	N/A
Completed	`NCT06025097` - Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.	Early Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.